Katerina Svigos
Overview
Explore the profile of Katerina Svigos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
37
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fried L, Laughter M, Svigos K, Kolla A, Gutierrez D, Shapiro J, et al.
J Drugs Dermatol
. 2023 Jan;
22(1):29-34.
PMID: 36607760
The treatment of primary scarring alopecias is challenging and patients may be susceptible to koebnerization. This predisposes cicatricial alopecia patients to worsening of their disease following procedural treatments or interventions....
2.
Laughter M, Anderson J, Kolla A, Svigos K, Pulsipher K, Mohammodu Z, et al.
J Drugs Dermatol
. 2022 Dec;
21(12):1316-1321.
PMID: 36468968
Background: Social media platforms continue to grow in popularity and have become common sources of medical information and education for patients struggling with hair loss. Objective: We sought to determine...
3.
Klein E, Karim M, Sukhdeo K, Svigos K, Yin L, Peterson E, et al.
JAAD Int
. 2022 Oct;
9:122-124.
PMID: 36248208
No abstract available.
4.
Curtiss P, Svigos K, Schwager Z, Lo Sicco K, Franks Jr A
J Am Acad Dermatol
. 2022 Jul;
90(2):237-248.
PMID: 35809802
Raynaud phenomenon (RP) presents with either primary or secondary disease, and both have the potential to negatively impact patient quality of life. First-line management of RP should include lifestyle modifications...
5.
Curtiss P, Svigos K, Schwager Z, Lo Sicco K, Franks Jr A
J Am Acad Dermatol
. 2022 Jul;
90(2):223-234.
PMID: 35809798
Raynaud's phenomenon (RP) is a relatively common disease with both primary and secondary forms. It is well understood as a vasospastic condition affecting the acral and digital arteries, resulting in...
6.
Yan D, Kolla A, Young T, Fried L, Shankar S, Rangel L, et al.
JAAD Int
. 2022 Apr;
8:31-33.
PMID: 35373153
No abstract available.
7.
Gutierrez D, Svigos K, Femia A, Brinster N, Lo Sicco K
JAAD Case Rep
. 2022 Mar;
22:107-109.
PMID: 35355654
No abstract available.
8.
Yin L, Klein E, Svigos K, Novice T, Gutierrez D, Oratz R, et al.
J Am Acad Dermatol
. 2022 Mar;
88(1):176-179.
PMID: 35278488
No abstract available.
9.
Gutierrez D, Peterson E, Svigos K, Femia A, Franks Jr A, Lo Sicco K
J Drugs Dermatol
. 2022 Feb;
21(2):206-208.
PMID: 35133119
Evidence-based literature regarding management of rare and severe dermatologic disease is limited. Canakinumab and anakinra, two therapeutics used for inhibiting IL-1 pathways, have seen increased utilization for treatment of refractory...
10.
Svigos K, Yin L, Fried L, Lo Sicco K, Shapiro J
Am J Clin Dermatol
. 2021 Aug;
22(5):681-692.
PMID: 34347282
Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching, burning or tenderness....